Literature DB >> 20666881

C-reactive protein point of care testing and physician communication skills training for lower respiratory tract infections in general practice: economic evaluation of a cluster randomized trial.

Jochen W L Cals1, Andre J H A Ament, Kerenza Hood, Christopher C Butler, Rogier M Hopstaken, Geert F Wassink, Geert-Jan Dinant.   

Abstract

RATIONALE, AIMS AND
OBJECTIVES: An economic evaluation of general practitioner (GP) use of C-reactive protein (CRP) point of care test, GP communication skills training, and both GP use of CRP and communication skills training on antibiotic use for lower respiratory tract infections (LRTIs) in general practice.
METHODS: Cost-effectiveness analysis with a time horizon of 28 days alongside a factorial, cluster randomized trial in 431 patients with LRTIs recruited by 40 GPs.
INTERVENTIONS: usual care (control group), GP use of CRP point of care test, GP communication skills training, and both CRP use and communication skills training. MAIN OUTCOME MEASURE: health care costs. Cost-effectiveness, using the primary outcome measure antibiotic prescribing at index consultation, was assessed by incremental cost-effectiveness ratios (ICER). To adjust for skewed data and clustering, we used non-parametric bootstrapping re-sampling to derive percentile intervals for the mean difference in total costs and the mean difference in effectiveness between the groups. Various implementation scenarios according to GP preference were modelled with corresponding net monetary benefit (NMB) curves based on a given willingness-to-pay (λ) for a 1% lower antibiotic prescribing rate.
RESULTS: The total mean cost per patient in the usual care group was €35.96 with antibiotic prescribing of 68%, €37.58 per patient managed by GPs using CRP tests (antibiotic prescribing 39%, ICER €5.79), €25.61 per patient managed by GPs trained in enhanced communication skills (antibiotic prescribing 33%, dominant) and €37.78 per patient managed by GPs using both interventions (antibiotic prescribing 23%, ICER €4.15). The interventions are cost-effective in any combination (yielding NMB at no willingness-to-pay), taking into account GPs' preferences where at least 15% of GPs chose to implement the communication skills training.
CONCLUSIONS: The two strategies, both singly and combined, are cost-effective interventions to reduce antibiotic prescribing for LRTI, at no, or low willingness-to-pay. Taking GP preferences into account will optimize investment in strategies to reduce antibiotic prescribing for LRTI.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20666881     DOI: 10.1111/j.1365-2753.2010.01472.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  31 in total

Review 1.  Economic Evidence and Point-of-Care Testing.

Authors:  Andrew St John; Christopher P Price
Journal:  Clin Biochem Rev       Date:  2013-08

2.  Incorrect inclusion of individual studies and methodological flaws in systematic review and meta-analysis.

Authors:  Rune Aabenhus; Jens-Ulrik S Jensen; Jochen Wl Cals
Journal:  Br J Gen Pract       Date:  2014-05       Impact factor: 5.386

3.  Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions.

Authors:  Raymond Oppong; Mark Jit; Richard D Smith; Christopher C Butler; Hasse Melbye; Sigvard Mölstad; Joanna Coast
Journal:  Br J Gen Pract       Date:  2013-07       Impact factor: 5.386

Review 4.  Can Patient-Provider Interpersonal Interventions Achieve the Quadruple Aim of Healthcare? A Systematic Review.

Authors:  Marie C Haverfield; Aaron Tierney; Rachel Schwartz; Michelle B Bass; Cati Brown-Johnson; Dani L Zionts; Nadia Safaeinili; Meredith Fischer; Jonathan G Shaw; Sonoo Thadaney; Gabriella Piccininni; Karl A Lorenz; Steven M Asch; Abraham Verghese; Donna M Zulman
Journal:  J Gen Intern Med       Date:  2020-01-09       Impact factor: 5.128

5.  Enhanced communication skills and C-reactive protein point-of-care testing for respiratory tract infection: 3.5-year follow-up of a cluster randomized trial.

Authors:  Jochen W L Cals; Leon de Bock; Pieter-Jan H W Beckers; Nick A Francis; Rogier M Hopstaken; Kerenza Hood; Eefje G P M de Bont; Christopher C Butler; Geert-Jan Dinant
Journal:  Ann Fam Med       Date:  2013 Mar-Apr       Impact factor: 5.166

Review 6.  Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies.

Authors:  Yafang Huang; Rui Chen; Tao Wu; Xiaoming Wei; Aimin Guo
Journal:  Br J Gen Pract       Date:  2013-11       Impact factor: 5.386

Review 7.  The next generation of rapid point-of-care testing identification tools for ventilator-associated pneumonia.

Authors:  Guillaume Millot; Benoit Voisin; Caroline Loiez; Frédéric Wallet; Saad Nseir
Journal:  Ann Transl Med       Date:  2017-11

Review 8.  Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews.

Authors:  Sarah Kg Tonkin-Crine; Pui San Tan; Oliver van Hecke; Kay Wang; Nia W Roberts; Amanda McCullough; Malene Plejdrup Hansen; Christopher C Butler; Chris B Del Mar
Journal:  Cochrane Database Syst Rev       Date:  2017-09-07

9.  C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.

Authors:  Nick A Francis; David Gillespie; Patrick White; Janine Bates; Rachel Lowe; Bernadette Sewell; Rhiannon Phillips; Helen Stanton; Nigel Kirby; Mandy Wootton; Emma Thomas-Jones; Kerenza Hood; Carl Llor; Jochen Cals; Hasse Melbye; Gurudutt Naik; Micaela Gal; Deborah Fitzsimmons; Mohammed Fasihul Alam; Evgenia Riga; Ann Cochrane; Christopher C Butler
Journal:  Health Technol Assess       Date:  2020-03       Impact factor: 4.014

Review 10.  Implications of Antibiotic Resistance for Patients' Recovery From Common Infections in the Community: A Systematic Review and Meta-analysis.

Authors:  Oliver van Hecke; Kay Wang; Joseph J Lee; Nia W Roberts; Chris C Butler
Journal:  Clin Infect Dis       Date:  2017-08-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.